FDA — authorised 29 October 1998
- Application: NDA020773
- Marketing authorisation holder: BRACCO
- Local brand name: SONORX
- Indication: SUSPENSION — ORAL
- Status: approved
🇺🇸 SIMETHICONE-CELLULOSE in United States
FDA authorised SIMETHICONE-CELLULOSE on 29 October 1998
Marketing authorisations
FDA
- Status: approved
SIMETHICONE-CELLULOSE in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is SIMETHICONE-CELLULOSE approved in United States?
Yes. FDA authorised it on 29 October 1998; FDA has authorised it.
Who is the marketing authorisation holder for SIMETHICONE-CELLULOSE in United States?
BRACCO holds the US marketing authorisation.